BRIEF-Nymox says new phase 3 long-term U.S.results for fexapotide show major decrease in prostate cancer
… . results for prostate
enlargement drug fexapotide show decrease in prostatecancer
* Fexapotide has … major reduction in
incidence of prostatecancer versus placebo
* Expects to file …
No comments:
Post a Comment